Clearmind submits psychedelic therapy recommendations to FDA
Go back to Clearmind submits psychedelic therapy recommendations to FDA| (NASDAQ: CMND) | Delayed: 6.10 +0.26 (4.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.84 | 52 Week High | $ | |||
| Open | $5.75 | 52 Week Low | $ | |||
| Day High | $6.22 | P/E | N/A | |||
| Day Low | $5.54 | EPS | $ | |||
| Volume | 109,801 | |||||



